Financial Planning & Analysis Manager
中美上海施贵宝制药有限公司 Sino-American Shanghai Squibb Pharmaceuticals Ltd.
- 公司规模:500-1000人
- 公司性质:合资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2020-10-29
- 工作地点:上海
- 招聘人数:1人
- 工作经验:3-4年经验
- 学历要求:本科
- 职位月薪:2.5-3万/月
- 职位类别:财务分析经理/主管 财务经理
职位描述
- Directly support BMS China Virology business; support key market access decisions, including pricing and distribution; support ad-hoc financial analysis and projects, as required
- Work closely with Virology BU; provide key financial input for business strategy and decision making; prepare annual budget and projection; work together with business partners to identify key business opportunities and challenges and drive business results.
- Collaborate with key market access functions, including Government Affairs, Key Account, Distribution, etc., to support the decision making of pricing and distribution strategies; play a key role in commercial policy, distributor agreement and pricing decision support
- Have the flexibility and willingness to be stretched and take on ad-hoc analysis and projects, as required
- Perform in-depth analysis on complex financial data and actual results; identify critical variance and communicate them to management with value-added suggestions.
- Closely collaborate with other finance functions, including accounting, internal control, tax, etc. to ensure accurate reporting and sound control under complex business environment.
- Develop analytical models to provide sensible financial reports and analysis through applicable software tools.
- Seek opportunities and bring innovative ideas to further improve current finance operation.
- Drive for greater system standardization and initiatives to reduce low value-added works.
公司介绍
百时美施贵宝是一家以“研发并提供创新药物,帮助患者战胜严重疾病”为使命的全球性生物制药公司。
2019年11月20日,百时美施贵宝成功完成了对新基的收购,将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一,打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列,并具有丰富的,且具有行业前景的产品管线。
如今,中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求,引领行业发展,开展多元合作,以帮助中国患者战胜严重疾病。
2019年11月20日,百时美施贵宝成功完成了对新基的收购,将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一,打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列,并具有丰富的,且具有行业前景的产品管线。
如今,中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求,引领行业发展,开展多元合作,以帮助中国患者战胜严重疾病。
联系方式
- 公司地址:地址:span南京